Repligen
$181.70Change from previous close: +2.52%Absolute change: +$4.47
At a glance
- Revenue growth
- +16.36%
- 2025 vs 2024
- Net margin
- 6.6%
- 2024: -4.0%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | 117 | 175 | 114 | 172 | — |
| Depreciation and amortization | 97.0 | 86.6 | 86.1 | 57.0 | — |
| Capital expenditure | -25.7 | -32.9 | -39.0 | -133 | — |
| Investing cash flow | -298 | -86.4 | -123 | -233 | — |
| Financing cash flow | -15.2 | -82.9 | 249 | -13.3 | — |
| Share repurchases | 0.0 | 0.0 | -14.4 | 0.0 | — |
| Debt issued | 0.0 | 0.0 | 290 | 0.0 | — |
| Debt repaid | 0.0 | -69.9 | 0.0 | 0.0 | — |
| Effect of exchange rates | 4.9 | -0.1 | -11.7 | -5.9 | — |
| Net change in cash | -196 | 6.1 | 240 | -74.5 | — |
| Free cash flow | 91.7 | 142 | 74.9 | 38.7 | — |